CGTX vs IDXX · $120.8M cap vs P/E 40, rev $2.36B
Cognition Therapeutics Inc (CGTX) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Cognition Therapeutics Inc (CGTX) is a biotechnology company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
CGTX does not have a complete income-statement cache yet.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
CGTX currently screens at market cap $120.8M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the CGTX and IDXX stock pages for the full models.
Not investment advice.